• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

executives

Teva
Biotech

Teva loses R&D head amid push to grow innovative medicines unit

Teva’s R&D chief Eric Hughes, M.D., Ph.D., has resigned one week after the company showcased its push to grow its innovative medicines business.
Nick Paul Taylor Nov 19, 2026 8:28am
Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o

Lilly International's Patrik Jonsson to retire—Chutes & Ladders

Oct 30, 2026 8:30am
Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o

GSK's Waterhouse tapped to helm struggling CSL—Chutes & Ladders

Oct 23, 2026 8:30am
Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o

Bausch + Lomb CEO heads for exit once more—Chutes & Ladders

Oct 16, 2026 8:30am
Silhouettes of women with different skin colors
Favicon Fierce Pharma

Fiercest Women in Life Sciences 2026: Nominations open now

Aug 4, 2026 10:00am
Sanofi

Sanofi replaces R&D chief as new CEO seeks to kickstart pipeline

Jun 22, 2026 3:48am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings